BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hou J, Yang Y, Chen N, Chen D, Hu S. Prognostic Value of Volume-Based Parameters Measured by SSTR PET/CT in Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:771912. [PMID: 34901087 DOI: 10.3389/fmed.2021.771912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Urso L, Castello A, Treglia G, Panareo S, Nieri A, Rambaldi I, Caracciolo M, Ortolan N, Uccelli L, Cittanti C, Castellani M, Bartolomei M. Relevance of Volumetric Parameters Applied to [(68)Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT. Diagnostics (Basel) 2023;13. [PMID: 36832093 DOI: 10.3390/diagnostics13040606] [Reference Citation Analysis]
2 Gallicchio R, Giordano A, Milella M, Storto R, Pellegrino T, Nardelli A, Nappi A, Tarricone L, Storto G. Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome in Patients With Primary Gastroenteropancreatic Neuroendocrine Tumors. Cancer Control 2023;30:10732748231152328. [PMID: 36714951 DOI: 10.1177/10732748231152328] [Reference Citation Analysis]
3 Weber M. Nicht nur bei NET: Somatostatinrezeptor-gerichtete Theranostik. InFo Hämatol Onkol 2022;25:17-21. [DOI: 10.1007/s15004-022-9013-7] [Reference Citation Analysis]